Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Malcolm Moore

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Living Beings

Physiology

Procedures

Colony-Forming Units Assay

Chemicals & Drugs

Disorders

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
37
Rafii, Shahin
21
Crystal, Ronald
19
Clarkson, Bayard
17
O'Reilly, Richard
13
Shieh, Jae-Hung
10
Welte, Karl
10
Muench, Marcus
10
Dias, Sergio
10
Heissig, Beate
9
Gabrilove, JL
9
Gillio, AP
8
Hackett, Neil
8
MacKenzie, Karen
7
Hicklin, Daniel
7
Witte, Larry

Sign-in to see all Coauthors

Publications

TOP 3
Dorn David C; Kou Cynthia A; Png Kim J; Moore Malcolm A S
The effect of cantharidins on leukemic stem cells.
Weisel Katja C; Moore Malcolm A S; Kanz Lothar; Möhle Robert
Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support.
Zheng Xiaomin; Oancea Claudia; Henschler Reinhard; Moore Malcolm A S; Ruthardt Martin
Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Malcolm Moore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Dorn David C; Kou Cynthia A; Png Kim J; Moore Malcolm A S
The effect of cantharidins on leukemic stem cells.
International journal of cancer. Journal international du cancer 2009;124(9):2186-99.
2009: Weisel Katja C; Moore Malcolm A S; Kanz Lothar; Möhle Robert
Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support.
Stem cells and development 2009;18(2):229-34.
2009: Zheng Xiaomin; Oancea Claudia; Henschler Reinhard; Moore Malcolm A S; Ruthardt Martin
Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.
PloS one 2009;4(10):e7661.
2008: Lee Gab Sang; Kim Byung Soo; Sheih Jae-Hung; Moore Malcolm
Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells.
Molecules and cells 2008;25(4):487-93.
2008: Bond Heather M; Mesuraca Maria; Amodio Nicola; Mega Tiziana; Agosti Valter; Fanello Delia; Pelaggi Daniela; Bullinger Lars; Grieco Michele; Moore Malcolm A S; Venuta Salvatore; Morrone Giovanni
Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells.
The international journal of biochemistry & cell biology 2008;40(5):848-54.
2007: Kim Kitai; Ng Kitwa; Rugg-Gunn Peter J; Shieh Jae-Hung; Kirak Oktay; Jaenisch Rudolf; Wakayama Teruhiko; Moore Malcolm A; Pedersen Roger A; Daley George Q
Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer.
Cell stem cell 2007;1(3):346-52.
2007: Lu Shi-Jiang; Feng Qiang; Caballero Sergio; Chen Yu; Moore Malcolm A S; Grant Maria B; Lanza Robert
Generation of functional hemangioblasts from human embryonic stem cells.
Nature methods 2007;4(6):501-9.
2007: Moore M A S; Chung K Y; Plasilova M; Schuringa J J; Shieh J-H; Zhou P; Morrone G
NUP98 dysregulation in myeloid leukemogenesis.
Annals of the New York Academy of Sciences 2007;1106():114-42.
2007: Moore Malcolm A S; Dorn David C; Schuringa Jan Jacob; Chung Ki Young; Morrone Giovanni
Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Experimental hematology 2007;35(4 Suppl 1):105-16.
2007: Wu Kai-Da; Zhou Li; Burtrum Douglas; Ludwig Dale L; Moore Malcolm A S
Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis.
Cancer immunology, immunotherapy : CII 2007;56(3):343-57.
2007: Angeles Angie R; Dorn David C; Kou Cynthia A; Moore Malcolm A S; Danishefsky Samuel J
Total synthesis of peribysin E necessitates revision of the assignment of its absolute configuration.
Angewandte Chemie (International ed. in English) 2007;46(9):1451-4.
2006: Chung Ki Y; Morrone Giovanni; Schuringa Jan Jacob; Plasilova Magdalena; Shieh Jae-Hung; Zhang Yue; Zhou Pengbo; Moore Malcolm A S
Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation.
Cancer research 2006;66(24):11781-91.
2006: Wen Victoria W; Wu Kaida; Baksh Sheik; Hinshelwood Rebecca A; Lock Richard B; Clark Susan J; Moore Malcolm A S; Mackenzie Karen L
Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
Cancer research 2006;66(22):10691-700.
2006: Weisel Katja C; Gao Ying; Shieh Jae-Hung; Moore Malcolm A S
Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis.
Experimental hematology 2006;34(11):1505-16.
2006: Baughn Linda B; Di Liberto Maurizio; Wu Kaida; Toogood Peter L; Louie Tracey; Gottschalk Rachel; Niesvizky Ruben; Cho Hearn; Ely Scott; Moore Malcolm A S; Chen-Kiang Selina
A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6.
Cancer research 2006;66(15):7661-7.
2006: He Wei; Dorn David C; Erdjument-Bromage Hediye; Tempst Paul; Moore Malcolm A S; Massagué Joan
Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.
Cell 2006;125(5):929-41.
2006: Moldenhauer Anja; Moore Malcolm A S; Schmidt Kerstin; Kiesewetter Holger; Salama Abdulgabar
Differences in the transmigration of different dendritic cells.
Experimental hematology 2006;34(6):745-52.
2006: Wierenga Albertus T J; Schepers Hein; Moore Malcolm A S; Vellenga Edo; Schuringa Jan Jacob
STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.
Blood 2006;107(11):4326-33.
2006: Moore Malcolm A S; Shieh Jae-Hung; Lee Gabsang
Hematopoietic cells.
Methods in enzymology 2006;418():208-42.
2005: Feugier Pierre; Li Na; Jo Deog-Yeon; Shieh Jae Hung; MacKenzie Karen L; Lesesve J F; Latger-Cannard V; Bensoussan D; Crystal Ronald G; Rafii Shahin; Stoltz J F; Moore Malcolm A S
Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro.
Stem cells and development 2005;14(5):505-16.
2005: Wu Kai-Da; Cho Young Shin; Katz Jonathan; Ponomarev Vladimir; Chen-Kiang Selina; Danishefsky Samuel J; Moore Malcolm A S
Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(30):10640-5.
2005: Moore Malcolm A S
Converging pathways in leukemogenesis and stem cell self-renewal.
Experimental hematology 2005;33(7):719-37.
2005: Weisel Katja C; Moore Malcolm A S
Genetic and functional characterization of isolated stromal cell lines from the aorta-gonado-mesonephros region.
Annals of the New York Academy of Sciences 2005;1044():51-9.
2005: Chung Ki Young; Morrone Giovanni; Schuringa Jan Jacob; Wong Bryan; Dorn David C; Moore Malcolm A S
Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis.
Blood 2005;105(1):77-84.
2005: Lanza Robert; Shieh J-H; Wettstein Peter J; Sweeney Raymond W; Wu Kaida; Weisz Anat; Borson Nancy; Henderson Boyd; West Michael D; Moore Malcolm A S
Long-term bovine hematopoietic engraftment with clone-derived stem cells.
Cloning and stem cells 2005;7(2):95-106.
2005: Wu Kai-da; Moore Malcolm A S
Determination of telomerase activity and telomere length.
Methods in molecular medicine 2005;113():207-23.
2004: Wang Eunice S; Teruya-Feldstein Julie; Wu Yan; Zhu Zhenping; Hicklin Daniel J; Moore Malcolm A S
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo.
Blood 2004;104(9):2893-902.
2004: Gaul Christoph; Njardarson Jón T; Shan Dandan; Dorn David C; Wu Kai-Da; Tong William P; Huang Xin-Yun; Moore Malcolm A S; Danishefsky Samuel J
The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis.
Journal of the American Chemical Society 2004;126(36):11326-37.
2004: Schuringa Jan Jacob; Chung Ki Young; Morrone Giovanni; Moore Malcolm A S
Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.
The Journal of experimental medicine 2004;200(5):623-35.
2004: Budak-Alpdogan Tulin; Alpdogan Onder; Banerjee Debabrata; Wang Eunice; Moore Malcolm A S; Bertino Joseph R
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(3):574-84.
2004: Moldenhauer Anja; Frank Richard C; Pinilla-Ibarz Javier; Holland Gudrun; Boccuni Piernicola; Scheinberg David A; Salama Abdulgabar; Seeger Karl; Moore Malcolm A S; Nimer Stephen D
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
Journal of leukocyte biology 2004;76(3):623-33.
2004: Gammaitoni Loretta; Weisel Katja C; Gunetti Monica; Wu Kai-Da; Bruno Stefania; Pinelli Silvana; Bonati Antonio; Aglietta Massimo; Moore Malcolm A S; Piacibello Wanda
Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication.
Blood 2004;103(12):4440-8.
2004: Nimer Stephen D; Moore Malcolm A S
Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.
Oncogene 2004;23(24):4249-54.
2004: Ye Q; Shieh J-H; Morrone G; Moore M A S
Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):777-87.
2004: Lanza Robert; Moore Malcolm A S; Wakayama Teruhiko; Perry Anthony C F; Shieh Jae-Hung; Hendrikx Jan; Leri Annarosa; Chimenti Stefano; Monsen Alyssa; Nurzynska Daria; West Michael D; Kajstura Jan; Anversa Piero
Regeneration of the infarcted heart with stem cells derived by nuclear transplantation.
Circulation research 2004;94(6):820-7.
2004: Agosti Valter; Corbacioglu Selim; Ehlers Imke; Waskow Claudia; Sommer Gunhild; Berrozpe Georgina; Kissel Holger; Tucker Christine M; Manova Katia; Moore Malcolm A S; Rodewald Hans-Reimer; Besmer Peter
Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development.
The Journal of experimental medicine 2004;199(6):867-78.
2004: Perez Lia E; Alpdogan Onder; Shieh Jae-Hung; Wong Donald; Merzouk Ahmed; Salari Hassan; O'Reilly Richard J; van den Brink Marcel R M; Moore Malcolm A S
Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice.
Experimental hematology 2004;32(3):300-7.
2004: Bond Heather M; Mesuraca Maria; Carbone Ennio; Bonelli Patrizia; Agosti Valter; Amodio Nicola; De Rosa Gennaro; Di Nicola Massimo; Gianni Alessandro M; Moore Malcolm A S; Hata Akiko; Grieco Michele; Morrone Giovanni; Venuta Salvatore
Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells.
Blood 2004;103(6):2062-70.
2004: Moore Malcolm A S
Commentary: the role of cell migration in the ontogeny of the lymphoid system.
Stem cells and development 2004;13(1):1-21.
2004: Wang Eunice S; Wu Kaida; Chin Allison C; Chen-Kiang Selina; Pongracz Krisztina; Gryaznov Sergei; Moore Malcolm A S
Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.
Blood 2004;103(1):258-66.
2004: Schuringa Jan Jacob; Wu Kaida; Morrone Giovanni; Moore Malcolm A S
Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Stem cells (Dayton, Ohio) 2004;22(7):1191-204.
2004: Moldenhauer A; Shieh J-H; Pruss A; Salama A; Moore M A S
Tumor necrosis factor alpha enhances the adenoviral transduction of CD34+ hematopoietic progenitor cells.
Stem cells (Dayton, Ohio) 2004;22(3):283-91.
2004: Moldenhauer Anja; Nociari Marcelo; Lam George; Salama Abdulgabar; Rafii Shahin; Moore Malcolm A S
Tumor necrosis factor alpha-stimulated endothelium: an inducer of dendritic cell development from hematopoietic progenitors and myeloid leukemic cells.
Stem cells (Dayton, Ohio) 2004;22(2):144-57.
2003: Mulloy James C; Cammenga Jorg; Berguido Francisco J; Wu Kaida; Zhou Ping; Comenzo Raymond L; Jhanwar Suresh; Moore Malcolm A S; Nimer Stephen D
Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element.
Blood 2003;102(13):4369-76.
2003: Barberi Tiziano; Klivenyi Peter; Calingasan Noel Y; Lee Hyojin; Kawamata Hibiki; Loonam Kathleen; Perrier Anselme L; Bruses Juan; Rubio Maria E; Topf Norbert; Tabar Viviane; Harrison Neil L; Beal M Flint; Moore Malcolm A S; Studer Lorenz
Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.
Nature biotechnology 2003;21(10):1200-7.
2003: Wang Eunice S; O'Connor Owen; She Yuhong; Zelenetz Andrew D; Sirotnak F M; Moore Malcolm A S
Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.
Leukemia & lymphoma 2003;44(6):1027-35.
2003: Wu Kai-Da; Orme Lisa M; Shaughnessy John; Jacobson Joth; Barlogie Bart; Moore Malcolm A S
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival.
Blood 2003;101(12):4982-9.
2003: Rafii Shahin; Avecilla Scott; Shmelkov Sergey; Shido Koji; Tejada Rafael; Moore Malcolm A S; Heissig Beate; Hattori Koichi
Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment.
Annals of the New York Academy of Sciences 2003;996():49-60.
2003: Sommer Gunhild; Agosti Valter; Ehlers Imke; Rossi Ferdinand; Corbacioglu Selim; Farkas Judith; Moore Malcolm; Manova Katia; Antonescu Cristina R; Besmer Peter
Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(11):6706-11.
2003: Moldenhauer A; Nociari M M; Dias S; Lalezari P; Moore M A S
Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes.
Vox sanguinis 2003;84(3):228-36.
2003: Franco S; Ozkaynak M F; Sandoval C; Tugal O; Jayabose S; Engelhardt M; Moore M A S
Telomere dynamics in childhood leukemia and solid tumors: a follow-up study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(2):401-10.
2002: Hattori Koichi; Heissig Beate; Wu Yan; Dias Sergio; Tejada Rafael; Ferris Barbara; Hicklin Daniel J; Zhu Zhenping; Bohlen Peter; Witte Larry; Hendrikx Jan; Hackett Neil R; Crystal Ronald G; Moore Malcolm A S; Werb Zena; Lyden David; Rafii Shahin
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.
Nature medicine 2002;8(8):841-9.
2002: MacKenzie Karen L; Franco Sonia; Naiyer Afzal J; May Chad; Sadelain Michel; Rafii Shahin; Moore Malcolm A S
Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
Oncogene 2002;21(27):4200-11.
2002: Heissig Beate; Hattori Koichi; Dias Sergio; Friedrich Matthias; Ferris Barbara; Hackett Neil R; Crystal Ronald G; Besmer Peter; Lyden David; Moore Malcolm A S; Werb Zena; Rafii Shahin
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.
Cell 2002;109(5):625-37.
2002: Boklan Jessica; Nanjangud Gouri; MacKenzie Karen L; May Chad; Sadelain Michel; Moore Malcolm A S
Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts.
Cancer research 2002;62(7):2104-14.
2002: Takebe Naoko; Xu Li-Cheng; MacKenzie Karen L; Bertino Joseph R; Moore Malcolm A S
Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
Cancer gene therapy 2002;9(3):308-20.
2002: Feugier Pierre; Jo Deog Yeon; Shieh Jae Hung; MacKenzie Karen L; Rafii Shahin; Crystal Ronald G; Moore Malcolm A S
Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand.
Journal of hematotherapy & stem cell research 2002;11(1):127-38.
2002: Moore Malcolm A S
Putting the neo into neoangiogenesis.
The Journal of clinical investigation 2002;109(3):313-5.
2002: Mulloy James C; Cammenga Jörg; MacKenzie Karen L; Berguido Francisco J; Moore Malcolm A S; Nimer Stephen D
The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.
Blood 2002;99(1):15-23.
2002: Moore Malcolm A S
Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing.
Journal of cellular biochemistry. Supplement 2002;38():29-38.
2001: Lane W J; Hattori K; Dias S; Peerschke E I; Moore M A; Blanset D L; Lang P C; Petrone M; Rafii S
Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation.
Experimental hematology 2001;29(12):1417-24.
2001: Lyden D; Hattori K; Dias S; Costa C; Blaikie P; Butros L; Chadburn A; Heissig B; Marks W; Witte L; Wu Y; Hicklin D; Zhu Z; Hackett N R; Crystal R G; Moore M A; Hajjar K A; Manova K; Benezra R; Rafii S
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth.
Nature medicine 2001;7(11):1194-201.
2001: Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin D J; Tateno M; Bohlen P; Moore M A; Rafii S
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(19):10857-62.
2001: Moore M A
The role of chemoattraction in cancer metastases.
BioEssays : news and reviews in molecular, cellular and developmental biology 2001;23(8):674-6.
2001: Franco S; MacKenzie K L; Dias S; Alvarez S; Rafii S; Moore M A
Clonal variation in phenotype and life span of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT).
Experimental cell research 2001;268(1):14-25.
2001: Moore M A; Hattori K; Heissig B; Shieh J H; Dias S; Crystal R G; Rafii S
Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
Annals of the New York Academy of Sciences 2001;938():36-45; discussion 45-7.
2001: Hattori K; Heissig B; Tashiro K; Honjo T; Tateno M; Shieh J H; Hackett N R; Quitoriano M S; Crystal R G; Rafii S; Moore M A
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.
Blood 2001;97(11):3354-60.
2001: Hattori K; Dias S; Heissig B; Hackett N R; Lyden D; Tateno M; Hicklin D J; Zhu Z; Witte L; Crystal R G; Moore M A; Rafii S
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.
The Journal of experimental medicine 2001;193(9):1005-14.
2000: Lane W J; Dias S; Hattori K; Heissig B; Choy M; Rabbany S Y; Wood J; Moore M A; Rafii S
Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases.
Blood 2000;96(13):4152-9.
2000: Kikuchi T; Miyazawa N; Moore M A; Crystal R G
Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.
Cancer research 2000;60(22):6391-5.
2000: Kikuchi T; Worgall S; Singh R; Moore M A; Crystal R G
Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4+ T cells.
Nature medicine 2000;6(10):1154-9.
2000: MacKenzie K L; Franco S; May C; Sadelain M; Moore M A
Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.
Experimental cell research 2000;259(2):336-50.
2000: Dias S; Hattori K; Zhu Z; Heissig B; Choy M; Lane W; Wu Y; Chadburn A; Hyjek E; Gill M; Hicklin D J; Witte L; Moore M A; Rafii S
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.
The Journal of clinical investigation 2000;106(4):511-21.
2000: MacKenzie K L; Hackett N R; Crystal R G; Moore M A
Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: assessment of transduction and toxicity in long-term culture.
Blood 2000;96(1):100-8.
2000: Kikuchi T; Moore M A; Crystal R G
Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors.
Blood 2000;96(1):91-9.
2000: Fushimi T; Kojima A; Moore M A; Crystal R G
Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.
The Journal of clinical investigation 2000;105(10):1383-93.
2000: Moore M A
Umbilical cord blood: an expandable resource.
The Journal of clinical investigation 2000;105(7):855-6.
2000: Han W; Ye Q; Moore M A
A soluble form of human Delta-like-1 inhibits differentiation of hematopoietic progenitor cells.
Blood 2000;95(5):1616-25.
2000: Engelhardt M; Mackenzie K; Drullinsky P; Silver R T; Moore M A
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Cancer research 2000;60(3):610-7.
2000: Peichev M; Naiyer A J; Pereira D; Zhu Z; Lane W J; Williams M; Oz M C; Hicklin D J; Witte L; Moore M A; Rafii S
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.
Blood 2000;95(3):952-8.
2000: Jo D Y; Rafii S; Hamada T; Moore M A
Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1.
The Journal of clinical investigation 2000;105(1):101-11.
1999: Naiyer A J; Jo D Y; Ahn J; Mohle R; Peichev M; Lam G; Silverstein R L; Moore M A; Rafii S
Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term culture-initiating cells) through endothelial cells is mediated by E-selectin.
Blood 1999;94(12):4011-9.
1999: Deshpande R V; Lalezari P; Pergolizzi R G; Moore M A
Structural abnormalities in the G-CSF receptor in severe congenital neutropenia.
Journal of hematotherapy & stem cell research 1999;8(4):411-20.
1999: Moore M A
"Turning brain into blood"--clinical applications of stem-cell research in neurobiology and hematology.
The New England journal of medicine 1999;341(8):605-7.
1999: Albanell J; Bosl G J; Reuter V E; Engelhardt M; Franco S; Moore M A; Dmitrovsky E
Telomerase activity in germ cell cancers and mature teratomas.
Journal of the National Cancer Institute 1999;91(15):1321-6.
1999: Möhle R; Bautz F; Rafii S; Moore M A; Brugger W; Kanz L
Regulation of transendothelial migration of hematopoietic progenitor cells.
Annals of the New York Academy of Sciences 1999;872():176-85; discussion 185-6.
1999: Worgall S; Singh R; Leopold P L; Kaner R J; Hackett N R; Topf N; Moore M A; Crystal R G
Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA.
Blood 1999;93(2):655-66.
1999: Moore M A; MacKenzie K L
Optimizing conditions for gene transfer into human hematopoietic cells.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progrès de la recherche expérimentale des tumeurs 1999;36():20-49.
1998: Frey B M; Rafii S; Crystal R G; Moore M A
[Adenovirus long-term expression of thrombopoietin in vivo: a new model for myeloproliferative syndrome and osteomyelofibrosis]
Schweizerische medizinische Wochenschrift 1998;128(42):1587-92.
1998: Tajima Y; Moore M A; Soares V; Ono M; Kissel H; Besmer P
Consequences of exclusive expression in vivo of Kit-ligand lacking the major proteolytic cleavage site.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(20):11903-8.
1998: Deshpande R V; Peterson R H; Moore M A
Granulocyte colony-stimulating factor activates protein kinase A in granulocytic but not monocytic precursors or neutrophils.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(8):579-86.
1998: Hamada T; Möhle R; Hesselgesser J; Hoxie J; Nachman R L; Moore M A; Rafii S
Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation.
The Journal of experimental medicine 1998;188(3):539-48.
1998: Narumi K; Suzuki M; Song W; Moore M A; Crystal R G
Intermittent, repetitive corticosteroid-induced upregulation of platelet levels after adenovirus-mediated transfer to the liver of a chimeric glucocorticoid-responsive promoter controlling the thrombopoietin cDNA.
Blood 1998;92(3):822-33.
1998: Möhle R; Bautz F; Rafii S; Moore M A; Brugger W; Kanz L
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.
Blood 1998;91(12):4523-30.
1998: Suzuki M; Singh R; Moore M A; Song W R; Crystal R G
Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genes.
Human gene therapy 1998;9(8):1223-31.
1998: Tajima Y; Huang E J; Vosseller K; Ono M; Moore M A; Besmer P
Role of dimerization of the membrane-associated growth factor kit ligand in juxtacrine signaling: the Sl17H mutation affects dimerization and stability-phenotypes in hematopoiesis.
The Journal of experimental medicine 1998;187(9):1451-61.
1998: Frey B M; Hackett N R; Bergelson J M; Finberg R; Crystal R G; Moore M A; Rafii S
High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors.
Blood 1998;91(8):2781-92.
1998: Slovin S F; Scher H I; Divgi C R; Reuter V; Sgouros G; Moore M; Weingard K; Pettengall R; Imbriaco M; El-Shirbiny A; Finn R; Bronstein J; Brett C; Milenic D; Dnistrian A; Shapiro L; Schlom J; Larson S M
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):643-51.
1998: Frey B M; Rafii S; Teterson M; Eaton D; Crystal R G; Moore M A
Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(2):691-9.
1998: Deshpande R V; Moore M A
G-CSF receptor-mediated up-regulation of c-fos but not c-raf mRNA expression in myeloid cells.
Molecular and cellular biochemistry 1998;178(1-2):47-50.
1998: Flasshove M; Banerjee D; Leonard J P; Mineishi S; Li M X; Bertino J R; Moore M A
Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA.
Human gene therapy 1998;9(1):63-71.
1998: Engelhardt M; Ozkaynak M F; Drullinsky P; Sandoval C; Tugal O; Jayabose S; Moore M A
Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(1):13-24.
1998: Möhle R; Rafii S; Moore M A
The role of endothelium in the regulation of hematopoietic stem cell migration.
Stem cells (Dayton, Ohio) 1998;16 Suppl 1():159-65.
1997: Möhle R; Salemi P; Moore M A; Rafii S
Expression of interleukin-5 by human bone marrow microvascular endothelial cells: implications for the regulation of eosinophilopoiesis in vivo.
British journal of haematology 1997;99(4):732-8.
1997: Engelhardt M; Drullinsky P; Guillem J; Moore M A
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1931-41.
1997: Rafii S; Mohle R; Shapiro F; Frey B M; Moore M A
Regulation of hematopoiesis by microvascular endothelium.
Leukemia & lymphoma 1997;27(5-6):375-86.
1997: Albanell J; Lonardo F; Rusch V; Engelhardt M; Langenfeld J; Han W; Klimstra D; Venkatraman E; Moore M A; Dmitrovsky E
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
Journal of the National Cancer Institute 1997;89(21):1609-15.
1997: Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher H I; Reuter V; Moore M A
Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(10):1849-57.
1997: Song W; Kong H L; Carpenter H; Torii H; Granstein R; Rafii S; Moore M A; Crystal R G
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.
The Journal of experimental medicine 1997;186(8):1247-56.
1997: Dalbagni G; Han W; Zhang Z F; Cordon-Cardo C; Saigo P; Fair W R; Herr H; Kim N; Moore M A
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1593-8.
1997: Shapiro F; Yao T J; Moskowitz C; Reich L; Wuest D L; Heimfeld S; McNiece I K; Gabrilove J; Nimer S; Moore M A
Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1571-8.
1997: Deshpande R V; Peterson R H; Moore M A
Granulocyte colony-stimulating factor-induced activation of protein kinase-C in myeloid cells.
Journal of cellular biochemistry 1997;66(3):286-96.
1997: Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore M A; Dmitrovsky E
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Differentiation; research in biological diversity 1997;61(5):321-31.
1997: Engelhardt M; Kumar R; Albanell J; Pettengell R; Han W; Moore M A
Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells.
Blood 1997;90(1):182-93.
1997: Cannizzo S J; Frey B M; Raffi S; Moore M A; Eaton D; Suzuki M; Singh R; Mack C A; Crystal R G
Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA.
Nature biotechnology 1997;15(6):570-3.
1997: Möhle R; Green D; Moore M A; Nachman R L; Rafii S
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):663-8.
1997: Möhle R; Moore M A; Nachman R L; Rafii S
Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line.
Blood 1997;89(1):72-80.
1997: Moore M A
Stem cell proliferation: ex vivo and in vivo observations.
Stem cells (Dayton, Ohio) 1997;15 Suppl 1():239-48; discussion 248-51.
1997: Szabolcs P; Ciocon D H; Moore M A; Young J W
Growth and differentiation of human dendritic cells from CD34+ progenitors.
Advances in experimental medicine and biology 1997;417():15-9.
1997: Deshpande R V; Peterson R H; Moore M A
Protein tyrosine kinases in granulocyte colony stimulating factor receptor signal transduction, myeloid cell proliferation, and neutrophil activation.
Life sciences 1997;60(9):587-604.
1996: Shapiro F; Pytowski B; Rafii S; Witte L; Hicklin D J; Yao T J; Moore M A
The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood.
Journal of hematotherapy 1996;5(6):655-62.
1996: Ohwada A; Rafii S; Moore M A; Crystal R G
In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression.
Blood 1996;88(3):778-84.
1996: Early E; Moore M A; Kakizuka A; Nason-Burchenal K; Martin P; Evans R M; Dmitrovsky E
Transgenic expression of PML/RARalpha impairs myelopoiesis.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(15):7900-4.
1996: Szabolcs P; Avigan D; Gezelter S; Ciocon D H; Moore M A; Steinman R M; Young J W
Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate.
Blood 1996;87(11):4520-30.
1996: Mesri E A; Cesarman E; Arvanitakis L; Rafii S; Moore M A; Posnett D N; Knowles D M; Asch A S
Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells.
The Journal of experimental medicine 1996;183(5):2385-90.
1996: Yurasov S V; Flasshove M; Rafii S; Moore M A
Density enrichment and characterization of hematopoietic progenitors and stem cells from umbilical cord blood.
Bone marrow transplantation 1996;17(4):517-25.
1996: Albanell J; Han W; Mellado B; Gunawardane R; Scher H I; Dmitrovsky E; Moore M A
Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
Cancer research 1996;56(7):1503-8.
1996: Moore M A; Leonard J P; Flasshove M; Bertino J; Gallardo H; Sadelain M
Gene therapy--the challenge for the future.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 2():53-8.
1995: Vahdat L; Raptis G; Fennelly D; Hamilton N; Reich L; Tiersten A; Harrison M; Hudis C; Moore M; Yao T J
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(11):1267-73.
1995: Rafii S; Shapiro F; Pettengell R; Ferris B; Nachman R L; Moore M A; Asch A S
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors.
Blood 1995;86(9):3353-63.
1995: Young J W; Szabolcs P; Moore M A
Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
The Journal of experimental medicine 1995;182(4):1111-9.
1995: Flasshove M; Banerjee D; Bertino J R; Moore M A
Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9 Suppl 1():S34-7.
1995: Moore M A
Expansion of myeloid stem cells in culture.
Seminars in hematology 1995;32(3):183-200.
1995: Szabolcs P; Moore M A; Young J W
Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(11):5851-61.
1995: Fennelly D; Schneider J; Spriggs D; Bengala C; Hakes T; Reich L; Barakat R; Curtin J; Moore M A; Hoskins W
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1160-6.
1995: Moore M A
Hematopoietic reconstruction: new approaches.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(1):3-9.
1995: Flasshove M; Banerjee D; Mineishi S; Li M X; Bertino J R; Moore M A
Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer.
Blood 1995;85(2):566-74.
1995: Szabolcs P; Feller E D; Moore M A; Young J W
Progenitor recruitment and in vitro expansion of immunostimulatory dendritic cells from human CD34+ bone marrow cells by c-kit-ligand, GM-CSF, and TNF alpha.
Advances in experimental medicine and biology 1995;378():17-20.
1994: Muench M O; Roncarolo M G; Namikawa R; Bárcena A; Moore M A
Progress in the ex vivo expansion of hematopoietic progenitors.
Leukemia & lymphoma 1994;16(1-2):1-11.
1994: Schneider J G; Crown J P; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore M A
Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Bone marrow transplantation 1994;14(6):877-84.
1994: Gasparetto C; Smith C; Gillio A; Stoppa A M; Moore M A; O'Reilly R J
Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta.
Bone marrow transplantation 1994;14(5):717-23.
1994: Shapiro F; Yao T J; Raptis G; Reich L; Norton L; Moore M A
Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer.
Blood 1994;84(10):3567-74.
1994: Rafii S; Shapiro F; Rimarachin J; Nachman R L; Ferris B; Weksler B; Moore M A; Asch A S
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion.
Blood 1994;84(1):10-9.
1994: Moore M A; Shapiro F
Regulation and function of hematopoietic stem cells.
Current opinion in hematology 1994;1(3):180-6.
1994: Shieh J H; Peterson R H; Moore M A
Bacterial endotoxin regulation of cytokine receptors on murine bone marrow cells: in vivo and in vitro study.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(2):859-66.
1994: Gasparetto C; Smith C; Firpo M; Dennig D; Small T; Gillio A P; Lichtenberg R; O'Reilly R J; Moore M A
Dyshematopoiesis in combined immune deficiency with congenital neutropenia.
American journal of hematology 1994;45(1):63-72.
1994: Moore M A; Hoskins I
Ex vivo expansion of cord blood-derived stem cells and progenitors.
Blood cells 1994;20(2-3):468-79; discussion 479-81.
1994: Moore M A; Schneider J G; Shapiro F; Bengala C
Ex vivo expansion of CD34+ hematopoietic progenitors.
Progress in clinical and biological research 1994;389():217-28.
1993: Gillio A P; Faulkner L B; Alter B P; Reilly L; Klafter R; Heller G; Young D C; Lipton J M; Moore M A; O'Reilly R J
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3.
Blood 1993;82(3):744-51.
1993: Gillio A P; Faulkner L B; Alter B P; Reilly L; Klafter R; Heller G; Young D C; Lipton J M; Moore M A; O'Reilly R J
Successful treatment of Diamond-Blackfan anemia with interleukin 3.
Stem cells (Dayton, Ohio) 1993;11 Suppl 2():123-30.
1993: Muench M O; Firpo M T; Moore M A
Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential.
Blood 1993;81(12):3463-73.
1993: Crown J; Kritz A; Vahdat L; Reich L; Moore M; Hamilton N; Schneider J; Harrison M; Gilewski T; Hudis C
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(6):1144-9.
1993: Shieh J H; Peterson R H; Moore M A
Cytokines and dexamethasone modulation of IL-1 receptors on human neutrophils in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(8 Pt 1):3515-24.
1993: Shieh J H; Gordon M; Jakubowski A; Peterson R H; Gabrilove J L; Moore M A
Interleukin-1 modulation of cytokine receptors on human neutrophils: in vitro and in vivo studies.
Blood 1993;81(7):1745-54.
1993: Smith C; Muench M O; Knizewski M; Gilboa E; Moore M A
Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(2):310-7.
1993: Moore M A
Ex vivo expansion and gene therapy using cord blood CD34+ cells.
Journal of hematotherapy 1993;2(2):221-4.
1992: Muench M O; Guy Z; Moore M A
Ex vivo differentiation therapy as a method of leukemic cell purging in murine bone marrow expansion cultures.
Cancer research 1992;52(23):6576-82.
1992: Muench M O; Gasparetto C; Moore M A
The in vitro growth of murine high proliferative potential-colony forming cells is not enhanced by growth in a low oxygen atmosphere.
Cytokine 1992;4(6):488-94.
1992: Steffen M; Budde-Steffen C; Gabrilove J L; Moore M A
Modulation of leukemic cell growth by tumor necrosis factor: action and expression in myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(7):634-41.
1992: Moore M A
Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it?
Blood 1992;80(1):3-7.
1992: Muench M O; Moore M A
Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors.
Experimental hematology 1992;20(5):611-8.
1992: Muench M O; Schneider J G; Moore M A
Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
Experimental hematology 1992;20(3):339-49.
1991: Moore M A
The use of colony stimulating factors in combination.
Current opinion in biotechnology 1991;2(6):854-62.
1991: Shieh J H; Peterson R H; Moore M A
Granulocyte colony-stimulating factor modulation of cytokine receptors on murine bone marrow cells. In vivo and in vitro studies.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(9):2984-90.
1991: Shieh J H; Peterson R H; Moore M A
IL-1 modulation of cytokine receptors on bone marrow cells. In vitro and in vivo studies.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(4):1273-8.
1991: Moore M A
Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators.
Blood 1991;78(1):1-19.
1991: Moore M A
The future of cytokine combination therapy.
Cancer 1991;67(10 Suppl):2718-26.
1991: Smith C; Gasparetto C; Collins N; Gillio A; Muench M O; O'Reilly R J; Moore M A
Purification and partial characterization of a human hematopoietic precursor population.
Blood 1991;77(10):2122-8.
1991: Lemoli R M; Gasparetto C; Scheinberg D A; Moore M A; Clarkson B D; Gulati S C
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
Blood 1991;77(8):1829-36.
1991: Shieh J H; Peterson R H; Moore M A
Modulation of granulocyte colony-stimulating factor receptors on murine peritoneal exudate macrophages by tumor necrosis factor-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(8):2648-53.
1991: Moore M A
The clinical use of colony stimulating factors.
Annual review of immunology 1991;9():159-91.
1990: Warren D J; Slørdal L; Moore M A
Tumor-necrosis factor induces cell cycle arrest in multipotential hematopoietic stem cells: a possible radioprotective mechanism.
European journal of haematology 1990;45(3):158-63.
1990: Slørdal L; Warren D J; Moore M A
Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy.
Cancer research 1990;50(14):4216-20.
1990: Moore M A; Stolfi R L; Martin D S
Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil.
Journal of the National Cancer Institute 1990;82(12):1031-7.
1990: Laver J; Duncan E; Abboud M; Gasparetto C; Sahdev I; Warren D; Bussel J; Auld P; O'Reilly R J; Moore M A
High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates.
The Journal of pediatrics 1990;116(4):627-32.
1990: Moore M A
Hematopoietic growth factors in cancer.
Cancer 1990;65(3 Suppl):836-44.
1990: Moore M A
Haemopoietic growth factor interactions: in vitro and in vivo preclinical evaluation.
Cancer surveys 1990;9(1):7-80.
1990: Moore M A; Muench M O; Warren D J; Laver J
Cytokine networks involved in the regulation of haemopoietic stem cell proliferation and differentiation.
Ciba Foundation symposium 1990;148():43-58; discussion 58-61.
1989: Slørdal L; Muench M O; Warren D J; Moore M A
Radioprotection by murine and human tumor-necrosis factor: dose-dependent effects on hematopoiesis in the mouse.
European journal of haematology 1989;43(5):428-34.
1989: Shieh J H; Peterson R H; Warren D J; Moore M A
Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(8):2534-9.
1989: Laver J; Moore M A
Clinical use of recombinant human hematopoietic growth factors.
Journal of the National Cancer Institute 1989;81(18):1370-82.
1989: Gasparetto C; Laver J; Abboud M; Gillio A; Smith C; O'Reilly R J; Moore M A
Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model.
Blood 1989;74(2):547-50.
1989: Steffen M; Abboud M; Potter G K; Yung Y P; Moore M A
Presence of tumour necrosis factor or a related factor in human basophil/mast cells.
Immunology 1989;66(3):445-50.
1989: Slørdal L; Warren D J; Moore M A
Effect of recombinant murine tumor necrosis factor on hemopoietic reconstitution in sublethally irradiated mice.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(3):833-5.
1989: Jakubowski A A; Souza L; Kelly F; Fain K; Budman D; Clarkson B; Bonilla M A; Moore M A; Gabrilove J
Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
The New England journal of medicine 1989;320(1):38-42.
1989: Moore M A
Interactions between hematopoietic growth factors in normal and leukemic stem cell differentiation.
Annals of the New York Academy of Sciences 1989;567():171-81.
1989: Laver J; Abboud M; Gasparetto C; Gillio A; Smith C; O'Reilly R J; Moore M A
Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy.
Biotherapy (Dordrecht, Netherlands) 1989;1(4):293-300.
1989: Moore M A
Interactions between hematopoietic growth factors: the clinical role of combination biotherapy.
Haematology and blood transfusion 1989;32():11-21.
1989: Moore M A
Role of interleukin-1 in hematopoiesis.
Immunologic research 1989;8(3):165-75.
1988: Wang S Y; Ho C K; Chen L Y; Wang R C; Huang M H; Castro-Malaspina H; Moore M A
Down regulation of myelopoiesis by mediators inhibiting the production of macrophage-derived granulomonopoietic enhancing activity (GM-EA).
Blood 1988;72(6):2001-6.
1988: Ottmann O G; Nocka K H; Moore M A; Pelus L M
Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(10):677-86.
1988: Laver J; Castro-Malaspina H; Kernan N A; Levick J; Evans R L; O'Reilly R J; Moore M A
In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin.
British journal of haematology 1988;69(4):545-50.
1988: Gabrilove J L; Jakubowski A; Scher H; Sternberg C; Wong G; Grous J; Yagoda A; Fain K; Moore M A; Clarkson B
Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia.
Behring Institute Mitteilungen 1988;(83):229-33.
1988: Gabrilove J L; Jakubowski A; Scher H; Sternberg C; Wong G; Grous J; Yagoda A; Fain K; Moore M A; Clarkson B
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.
The New England journal of medicine 1988;318(22):1414-22.
1988: Steffen M; Ottmann O G; Moore M A
Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(8):2621-4.
1988: Steffen M; Cayre Y; Manogue K R; Moore M A
1,25-Dihydroxyvitamin D3 transcriptionally regulates tumour necrosis factor mRNA during HL-60 cell differentiation.
Immunology 1988;63(1):43-6.
1988: Warren D J; Moore M A
Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(1):94-9.
1988: Steinberg J; Bona C; Polyzos A; Moore M A; Platsoucas C D
Proliferation of leukemic B cells in response to SAC and anti-mu. Evidence for different modes of action and comparison to proliferation and differentiation induced by conditioned medium.
Leukemia research 1988;12(7):559-66.
1987: Moore M A; Warren D J
Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(20):7134-8.
1987: Welte K; Bonilla M A; Gillio A P; Boone T C; Potter G K; Gabrilove J L; Moore M A; O'Reilly R J; Souza L M
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.
The Journal of experimental medicine 1987;165(4):941-8.
1987: Welte K; Bonilla M A; Gabrilove J L; Gillio A P; Potter G K; Moore M A; O'Reilly R J; Boone T C; Souza L M
Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis.
Blood cells 1987;13(1-2):17-30.
1987: Ottmann O G; Welte K; Souza L M; Moore M A
Proliferative effects of a recombinant human granulocyte colony-stimulating factor (rG-CSF) on highly enriched hematopoietic progenitor cells.
Haematology and blood transfusion 1987;31():244-7.
1987: Moore M A; Welte K; Gabrilove J; Souza L M
Biological activities of recombinant human granulocyte colony stimulating factor (rhG-CSF) and tumor necrosis factor: in vivo and in vitro analysis.
Haematology and blood transfusion 1987;31():210-20.
1986: Platzer E; Oez S; Welte K; Sendler A; Gabrilove J L; Mertelsmann R; Moore M A; Kalden J R
Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells.
Immunobiology 1986;172(3-5):185-93.
1986: Lu L; Pelus L M; Broxmeyer H E; Moore M A; Wachter M; Walker D; Platzer E
Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E.
Blood 1986;68(1):126-33.
1986: Gabrilove J L; Welte K; Harris P; Platzer E; Lu L; Levi E; Mertelsmann R; Moore M A
Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(8):2478-82.
1985: Platzer E; Welte K; Gabrilove J L; Lu L; Harris P; Mertelsmann R; Moore M A
Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells.
The Journal of experimental medicine 1985;162(6):1788-801.
1985: Merluzzi V J; Savage D M; Smith M D; Last-Barney K; Mertelsmann R; Moore M A; Welte K
Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(3):1702-6.
1985: Potter G K; Mohamed A N; Dracopoli N C; Groshen S L; Shen R N; Moore M A
Action of 1,25-(OH)2D3 in nude mice bearing transplantable human myelogenous leukemic cell lines.
Experimental hematology 1985;13(8):722-32.
1985: Wang S Y; Castro-Malaspina H; Moore M A
Long-term culture of human bone marrow macrophages: macrophage development is associated with the production of granulomonopoietic enhancing activity (GM-EA).
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1186-93.
1985: Gabrilove J L; Welte K; Lu L; Castro-Malaspina H; Moore M A
Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor.
Blood 1985;66(2):407-15.
1985: Ebell W; Castro-Malaspina H; Moore M A; O'Reilly R J
Depletion of stromal cell elements in human marrow grafts separated by soybean agglutinin.
Blood 1985;65(5):1105-11.
1985: Wang S Y; Castro-Malaspina H; Lu L; Moore M A
Biological characterization of a granulomonopoietic enhancing activity derived from cultured human lipid-containing macrophages.
Blood 1985;65(5):1181-90.
1985: Arlin Z A; Mertelsmann R; Berman E; Gee T; Kurland E; Chaganti R S; Jhanwar S C; Moore M A; Clarkson B D
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(4):473-6.
1985: Siena S; Castro-Malaspina H; Gulati S C; Lu L; Colvin M O; Clarkson B D; O'Reilly R J; Moore M A
Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow.
Blood 1985;65(3):655-62.
1985: Yung Y P; Okumura K; Moore M A
Generation of natural killer cell lines from murine long-term bone marrow cultures.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(3):1462-8.
1985: Welte K; Platzer E; Lu L; Gabrilove J L; Levi E; Mertelsmann R; Moore M A
Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(5):1526-30.
1985: Platzer E; Rubin B Y; Lu L; Welte K; Broxmeyer H E; Moore M A
OKT3 monoclonal antibody induces production of colony-stimulating factor(s) for granulocytes and macrophages in cultures of human T lymphocytes and adherent cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(1):265-71.
1985: Lu L; Broxmeyer H E; Moore M A; Sheridan A P; Gentile P
Abnormalities in myelopoietic regulatory interactions with acidic isoferritins and lactoferrin in mice infected with Friend virus complex: association with altered expression of Ia antigens on effector and responding cells.
Blood 1985;65(1):91-9.
1985: Yung Y P; Moore M A
Mast-cell growth factor: its role in mast-cell differentiation, proliferation, and maturation.
Contemporary topics in molecular immunology 1985;10():147-79.
1985: Platzer E; Welte K; Lu L; Gabrilove J L; Yung Y P; Nathan C F; Mertelsmann R; Moore M A
Biological activities of a human pluripotent hemopoietic colony-stimulating factor.
Haematology and blood transfusion 1985;29():418-22.
1985: Welte K; Platzer E; Gabrilove J L; Lu L; Levi E; Polivka A; Mertelsmann R; Moore M A
Purification to apparent homogeneity and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.
Haematology and blood transfusion 1985;29():398-401.
1984: Welte K; Andreeff M; Platzer E; Holloway K; Rubin B Y; Moore M A; Mertelsmann R
Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes.
The Journal of experimental medicine 1984;160(5):1390-403.
1984: Mertelsmann R; Welte K; Sternberg C; O'Reilly R; Moore M A; Clarkson B D; Oettgen H F
Treatment of immunodeficiency with interleukin-2: initial exploration.
Journal of biological response modifiers 1984;3(5):483-90.
1984: Welte K; Ciobanu N; Moore M A; Gulati S; O'Reilly R J; Mertelsmann R
Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2.
Blood 1984;64(2):380-5.
1984: Kruger G; Welte K; Ciobanu N; Cunningham-Rundles C; Ralph P; Venuta S; Feldman S; Koziner B; Wang C Y; Moore M A
Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.
Journal of clinical immunology 1984;4(4):295-303.
1984: Ralph P; Welte K; Levi E; Nakoinz I; Litcofsky P B; Mertelsmann R H; Moore M A
Human B cell-inducing factor(s) for production of IgM, IgG and IgA: independence from IL 2.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(4):1858-62.
1984: Moore M A; Gabrilove J; Lu L; Yung Y P
Myeloid and erythroid stem cells: regulation in normal and neoplastic states.
Symposium on Fundamental Cancer Research 1984;37():147-58.
1983: Ralph P; Harris P E; Punjabi C J; Welte K; Litcofsky P B; Ho M K; Rubin B Y; Moore M A; Springer T A
Lymphokine inducing "terminal differentiation" of the human monoblast leukemia line U937: a role for gamma interferon.
Blood 1983;62(6):1169-75.
1983: Welte K; Platzer E; Wang C Y; Rinnooy Kan E A; Moore M A; Mertelsmann R
OKT8 antibody inhibits OKT3-induced IL 2 production and proliferation in OKT8+ cells.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(5):2356-61.
1983: Gold E J; Mertelsmann R H; Itri L M; Gee T; Arlin Z; Kempin S; Clarkson B; Moore M A
Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes.
Cancer treatment reports 1983;67(11):981-6.
1983: Ciobanu N; Welte K; Kruger G; Venuta S; Gold J; Feldman S P; Wang C Y; Koziner B; Moore M A; Safai B
Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2.
Journal of clinical immunology 1983;3(4):332-40.
1983: Gold E J; Conjalka M; Pelus L M; Jhanwar S C; Broxmeyer H; Middleton A B; Clarkson B D; Moore M A
Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(10):627-34.
1983: Maurer D H; Welte K; Mertelsmann R; Moore M A; Ralph P
Lymphokine factors inducing IgG production in human B-cell line ARH-77 and stimulatory effects of phorbol ester tumor promoter.
Cellular immunology 1983;79(1):36-43.
1983: Yung Y P; Wang S Y; Moore M A
Characterization of mast cell precursors by physical means: dissociation from T cells and T cell precursors.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(6):2843-8.
1983: Punjabi C J; Moore M A; Ralph P
Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells.
Cellular immunology 1983;77(1):13-22.
1983: Feldman S P; Mertelsmann R; Venuta S; Andreeff M; Welte K; Moore M A
Sodium azide enhancement of interleukin-2 production.
Blood 1983;61(4):815-8.
1983: Venuta S; Mertelsmann R; Welte K; Feldman S P; Wang C Y; Moore M A
Production and regulation of interleukin-2 in human lymphoblastic leukemias studied with T-cell monoclonal antibodies.
Blood 1983;61(4):781-9.
1983: Lu L; Broxmeyer H E; Meyers P A; Moore M A; Thaler H T
Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins.
Blood 1983;61(2):250-6.
1983: Welte K; Venuta S; Wang C Y; Feldman S P; Ciobanu N; Kruger G; Feickert H J; Merluzzi V J; Flomenberg N; Moore M A; Mertelsmann R
Human interleukin 2: physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromes.
Haematology and blood transfusion 1983;28():369-79.
1983: Moore M A; Gabrilove J; Sheridan A P
Therapeutic implications of serum factors inhibiting proliferation and inducing differentiation of myeloid leukemic cells.
Blood cells 1983;9(1):125-44.
1983: Moore M A; Gabrilove J; Sheridan A P
Myeloid leukemic cell differentiation induced by human postendotoxin serum and vitamin analogues.
Haematology and blood transfusion 1983;28():327-37.
1983: Yung Y P; Moore M A
Mast cell growth factor.
Lymphokine research 1983;2(4):127-31.
1982: Yung Y P; Moore M A
Long-term in vitro culture of murine mast cells. III. Discrimination of mast cells growth factor and granulocyte-CSF.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(3):1256-61.
1982: Ralph P; Williams N; Moore M A; Litcofsky P B
Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester.
Cellular immunology 1982;71(2):215-23.
1982: Castro-Malaspina H; Gay R E; Jhanwar S C; Hamilton J A; Chiarieri D R; Meyers P A; Gay S; Moore M A
Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders.
Blood 1982;59(5):1046-54.
1982: Pelus L M; Saletan S; Silver R T; Moore M A
Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E.
Blood 1982;59(2):284-92.
1982: Steinmann G; Broxmeyer H E; de Harven E; Moore M A
Immuno-electron microscopic tracing of lactoferrin, a regulator of myelopoiesis, into a subpopulation of human peripheral blood monocytes.
British journal of haematology 1982;50(1):75-84.
1982: Mertelsmann R; Moore M A; Clarkson B
Leukemia cell phenotype and prognosis: an analysis of 519 adults with acute leukemia.
Blood cells 1982;8(3):561-83.
1982: Moore M A
G-CSF: its relationship to leukemia differentiation-inducing activity and other hemopoietic regulators.
Journal of cellular physiology. Supplement 1982;1():53-64.
1982: Castro-Malaspina H; Moore M A
Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
Nouvelle revue française d'hématologie 1982;24(4):221-6.
1981: Gillis S; Mertelsmann R; Moore M A
T-cell growth factor (interleukin 2) control of T-lymphocyte proliferation: possible involvement in leukemogenesis.
Transplantation proceedings 1981;13(4):1884-90.
1981: Mertelsmann R; Moore M A; Broxmeyer H E; Cirrincione C; Clarkson B
Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia.
Cancer research 1981;41(11 Pt 2):4844-8.
1981: Lu L; Broxmeyer H E; Pelus L M; Andreeff M; Moore M A
Detection of luxol-fast-blue positive cells in human promyelocytic leukemia cell line HL-60.
Experimental hematology 1981;9(9):887-92.
1981: Pelus L M; Broxmeyer H E; Moore M A
Regulation of human myelopoiesis by prostaglandin E and lactoferrin.
Cell and tissue kinetics 1981;14(5):515-26.
1981: Tertian G; Yung Y P; Guy-Grand D; Moore M A
Long-term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(2):788-94.
1981: Mertelsmann R; Gillis S; Steinmann G; Ralph P; Stiehm M; Koziner B; Moore M A
T-cell growth factor (interleukin 2) and terminal transferase activity in human leukemias and lymphoblastic cell lines.
Blut 1981;43(2):99-103.
1981: Yung Y P; Eger R; Tertian G; Moore M A
Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(2):794-9.
1981: Stuart R K; Hamilton J A; Sensenbrenner L L; Moore M A
Regulation of myelopoiesis in vitro: partial replacement of colony-stimulating factors by tumor-promoting phorbol esters.
Blood 1981;57(6):1032-42.
1981: Castro-Malaspina H; Rabellino E M; Yen A; Nachman R L; Moore M A
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts.
Blood 1981;57(4):781-7.
1981: Pelus L M; Broxmeyer H E; DeSousa M; Moore M A
Heterogeneity among resident murine peritoneal macrophages: separation and functional characterization of monocytoid cells producing granulocyte-macrophage colony-stimulating factor (GM-CSF) and responding to regulation by lactoferrin.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(3):1016-21.
1981: Steinmann G; Mertelsmann R; deHarven E; Moore M A
Ultrastructural demonstration of terminal deoxynucleotidyl transferase (TdT).
Blood 1981;57(2):368-71.
1981: Moore M A
Genetic and oncogenic influences on myelopoiesis.
Haematology and blood transfusion 1981;26():237-42.
1981: Mertelsmann R; Moore M A; Clarkson B
Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells.
Haematology and blood transfusion 1981;26():68-72.
1981: Moore M A; Mertelsmann R; Pelus L M
Phenotypic evaluation of chronic myeloid leukemia.
Blood cells 1981;7(2):217-36.
1980: Tertian G; Dy M; Yung Y P; Guy-Grand D; Moore M A; Hamburger J
[Production of a mastocyte growth factor in lymphocyte cultures stimulated by a mitogen or by allogenic cells]
Comptes rendus des séances de l'Académie des sciences. Série D, Sciences naturelles 1980;291(13):1041-6.
1980: Straus D J; Mertelsmann R; Koziner B; McKenzie S; de Harven E; Arlin Z A; Kempin S; Broxmeyer H; Moore M A; Menendez-Botet C J; Gee T S; Clarkson B D
The acute monocytic leukemias: multidisciplinary studies in 45 patients.
Medicine 1980;59(6):409-25.
1980: Castro-Malaspina H; Gay R E; Resnick G; Kapoor N; Meyers P; Chiarieri D; McKenzie S; Broxmeyer H E; Moore M A
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.
Blood 1980;56(2):289-301.
1980: Gulati S C; Mertelsmann R; Gee T; Good R A; Clarkson B; Moore M A; Koziner B
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease.
Cancer 1980;46(4):725-9.
1980: Pelus L M; Broxmeyer H E; Clarkson B D; Moore M A
Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Cancer research 1980;40(7):2512-5.
1980: Ito M; Ralph P; Moore M A
Suppression of spleen natural killing activity induced by BCG.
Clinical immunology and immunopathology 1980;16(1):30-8.
1980: Kurland J I; Meyers P A; Moore M A
Synthesis and release of erythroid colony- and burst-potentiating activities by purified populations of murine peritoneal macrophages.
The Journal of experimental medicine 1980;151(4):839-52.
1980: Moore M A; Broxmeyer H E; Sheridan A P; Meyers P A; Jacobsen N; Winchester R J
Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells.
Blood 1980;55(4):682-90.
1980: Jacobsen N; Broxmeyer H E; Winchester R J; Moore M A
Expression of DR antigens on early human progenitors of neutrophilic and eosinophilic colonies in diffusion chambers (CFUd).
Scandinavian journal of haematology 1980;24(3):227-33.
1980: Wright E G; Sheridan P; Moore M A
An inhibitor of murine stem cell proliferation produced by normal human bone marrow.
Leukemia research 1980;4(3):309-14.
1980: Modak M J; Mertelsmann R; Koziner B; Pahwa R; Moore M A; Clarkson B D; Good R A
A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias.
Journal of cancer research and clinical oncology 1980;98(1):91-104.
1980: Tertian G; Yung Y P; Moore M A
Induction and long-term maintenance of Thy-1 positive T lymphocytes: derivation from continuous bone marrow cultures.
Journal of supramolecular structure 1980;13(4):533-9.
1979: Moore M A; Sheridan A P; Allen T D; Dexter T M
Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment.
Blood 1979;54(4):775-93.
1979: Paige C J; Kincade P W; Moore M A; Lee G
The fate of fetal and adult B-cell progenitors grafted into immunodeficient CBA/N mice.
The Journal of experimental medicine 1979;150(3):548-63.
1979: Ito M; Ralph P; Moore M A
In vitro stimulation of phagocytosis in a macrophage cell line measured by a convenient radiolabeled latex bead assay.
Cellular immunology 1979;46(1):48-56.
1979: Broxmeyer H E; Grossbard E; Jacobsen N; Moore M A
Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia.
The New England journal of medicine 1979;301(7):346-51.
1979: Pelus L M; Broxmeyer H E; Kurland J I; Moore M A
Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin.
The Journal of experimental medicine 1979;150(2):277-92.
1979: Kincade P W; Lee G; Fernandes G; Moore M A; Williams N; Good R A
Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(7):3464-8.
1979: Moore M A; Sheridan A P
Pluripotential stem cell replication in continuous human, prosimian, and murine bone marrow culture.
Blood cells 1979;5(2):297-311.
1979: Moore M A
Humoral regulation of granulopoiesis.
Clinics in haematology 1979;8(2):287-309.
1979: Kurland J I; Pelus L M; Ralph P; Bockman R S; Moore M A
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(5):2326-30.
1979: Jacobsen N; Broxmeyer H E; Grossbard E; Moore M A
Colony-forming units in diffusion chambers (CFU-d) and colony-forming units in agar culture (CFU-c) obtained from normal human bone marrow: a possible parent-progeny relationship.
Cell and tissue kinetics 1979;12(2):213-26.
1979: Broxmeyer H E; Ralph P; Margolis V B; Nakoinz I; Meyers P; Kapoor N; Moore M A
Characteristics of bone marrow and blood cells in human leukemia that produce leukemia inhibitory activity (LIA).
Leukemia research 1979;3(4):193-203.
1979: Mertelsmann R; Koziner B; Filippa D A; Grossbard E; Incefy G; Moore M A; Clarkson B D
Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias.
Haematology and blood transfusion 1979;23():131-8.
1979: Mertelsmann R; Filippa D A; Koziner B; Grossbard E; Beck J; Moore M A; Lieberman P H; Clarkson B D; Gupta S; Good R A
Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomas.
Advances in experimental medicine and biology 1979;114():553-60.
1979: Moore M A
Regulatory interactions in normal and leukemic myelopoiesis.
Haematology and blood transfusion 1979;23():171-80.
1979: Moore M A
Interpretations of culture data in aplastic anemia: evidence for a suppressor cell involvement.
Haematology and blood transfusion 1979;24():265-71.
1978: Broxmeyer H E; Moore M A
Communication between white cells and the abnormalities of this in leukemia.
Biochimica et biophysica acta 1978;516(2):129-66.
1978: Kincade P W; Moore M A; Lee G; Paige C J
Colony-forming B cells in F1 hybrid and transplanted CBA/N mice.
Cellular immunology 1978;40(2):294-302.
1978: Hamilton J A; Ralph P; Moore M A
A macrophage tumor cell line and plasminogen activator. A potential model system for macrophage regulation of enzyme production.
The Journal of experimental medicine 1978;148(3):811-6.
1978: Mertelsmann R; Koziner B; Moore M A
TdT activity in B cell ALL.
Blood 1978;52(3):638-9.
1978: Winchester R J; Meyers P A; Broxmeyer H E; Wang C Y; Moore M A; Kunkel H G
Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera.
The Journal of experimental medicine 1978;148(2):613-8.
1978: Kurland J I; Broxmeyer H E; Pelus L M; Bockman R S; Moore M A
Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation.
Blood 1978;52(2):388-407.
1978: Delmonte L; Williams N; Moore M A
Effect of myleran on murine hemopoiesis. III. Changes in the density distribution of spleen colony forming (CFU-S) and agar gel colony forming cells (CFU-C).
Cell and tissue kinetics 1978;11(4):369-75.
1978: Jacobsen N; Broxmeyer H E; Grossbard E; Moore M A
Diversity of human granulopoietic precursor cells: separation of cells that form colonies in diffusion chambers (CFU-d) from populations of colony-forming cells in vitro (CFU-c) by velocity sedimentation.
Blood 1978;52(1):221-32.
1978: Williams N; Eger R R; Moore M A; Mendelsohn N
Differentiation of mouse bone marrow precursor cells into neutrophil granulocytes by an activity separation from WEHI-3 cell-conditioned medium.
Differentiation; research in biological diversity 1978;11(1):59-63.
1978: Mertelsmann R; Koziner B; Ralph R; Filippa D; McKenzie S; Arlin Z A; Gee T S; Moore M A; Clarkson B D
Evidence for distinct lymphocytic and monocytic populations in a patient with terminal transferase--positive acute leukemia.
Blood 1978;51(6):1051-6.
1978: Ralph P; Broxmeyer H E; Moore M A; Nakoinz I
Induction of myeloid colony-stimulating activity in murine monocyte tumor cell lines by macrophage activators and in a T-cell line by concanavalin A.
Cancer research 1978;38(5):1414-9.
1978: Mendelsohn N; Eger R R; Broxmeyer H E; Moore M A
Isolation of a granulocyte colony inhibitory factor derived from human polymorphonuclear neutrophils.
Biochimica et biophysica acta 1978;533(1):238-47.
1978: Moore M A; Dexter T M
Stem cell regulation in continuous hematopoietic cell culture.
Transplantation proceedings 1978;10(1):83-90.
1978: Kurland J I; Traganos F; Darzynkiewicz Z; Moore M A
Macrophage-mediated cytostasis of neoplastic hemopoietic cells: cytofluorometric analysis of the reversible cell cycle block.
Cellular immunology 1978;36(2):318-30.
1978: Broxmeyer H E; Grossbard E; Jacobsen N; Moore M A
Evidence for a proliferative advantage of human leukemia colony-forming cells in vitro.
Journal of the National Cancer Institute 1978;60(3):513-21.
1978: Williams N; Jackson H; Sheridan A P; Murphy M J; Elste A; Moore M A
Regulation of megakaryopoiesis in long-term murine bone marrow cultures.
Blood 1978;51(2):245-55.
1978: Kurland J I; Bockman R S; Broxmeyer H E; Moore M A
Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E.
Science (New York, N.Y.) 1978;199(4328):552-5.
1978: Moore M A
The role of factors in differentiation of non-erythroid cells.
The symposium / The Society for Developmental Biology. Society for Developmental Biology. Symposium 1978;(35):181-8.
1977: Kurland J I; Hadden J W; Moore M A
Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells.
Cancer research 1977;37(12):4534-8.
1977: Shah R G; Caporale L H; Moore M A
Characterization of colony-stimulating activity produced by human monocytes and phytohemagglutinin-stimulated lymphocytes.
Blood 1977;50(5):811-21.
1977: Kurland J I; Kincade P W; Moore M A
Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors.
The Journal of experimental medicine 1977;146(5):1420-35.
1977: Dexter T M; Moore M A
In vitro duplication and "cure" of haemopoietic defects in genetically anaemic mice.
Nature 1977;269(5627):412-4.
1977: Kurland J; Moore M A
Modulation of hemopoiesis by prostaglandins.
Experimental hematology 1977;5(5):357-73.
1977: Horland A A; Wolman S R; Murphy M J; Moore M A
Proliferation of erythroid colonies in semi-solid agar.
British journal of haematology 1977;36(4):495-9.
1977: Dexter T M; Moore M A; Sheridan A P
Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro.
The Journal of experimental medicine 1977;145(6):1612-6.
1977: Broxmeyer H E; Moore M A; Ralph P
Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils.
Experimental hematology 1977;5(2):87-102.
1977: Moore M A
In vitro culture studies in chronic granulocytic leukaemia.
Clinics in haematology 1977;6(1):97-112.
1977: Gabourel J D; Moore M A; Bagby G C; Davies G H
Effect of sodium salicylate on human and mouse granulopoiesis in vitro.
Arthritis and rheumatism 1977;20(1):59-64.
1976: Moore M A; Hansen J A; Everson L K; O'Reilly R; Good R A
Hematologic analysis of clinical bone marrow grafting evaluated by in vitro cultures.
Transplantation proceedings 1976;8(4):647-54.
1976: Kagan W A; Ascensão J A; Pahwa R N; Hansen J A; Goldstein G; Valera E B; Incefy G S; Moore M A; Good R A
Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(8):2890-4.
1976: Moore M A
Regulatory role of macrophages in hemopoiesis.
Journal of the Reticuloendothelial Society 1976;20(1):89-91.
1976: Ralph P; Moore M A; Nilsson K
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.
The Journal of experimental medicine 1976;143(6):1528-33.
1976: Kincade P W; Ralph P; Moore M A
Growth of B-lymphocytes clones in semisolid culture is mitogen dependent.
The Journal of experimental medicine 1976;143(5):1265-70.
1976: Moore M A
Prediction of relapse and remission in AML by marrow culture criteria.
Nouvelle revue française d'hématologie; blood cells 1976;17(1-2):109-24.
1975: Johnson G R; Moore M A
Role of stem cell migration in initiation of mouse foetal liver haemopoiesis.
Nature 1975;258(5537):726-8.
1975: Kincade P W; Moore M A; Schlegel R A; Pye J
B lymphocyte differentiation from fetal liver stem cells in89 Sr-treated mice1.
Journal of immunology (Baltimore, Md. : 1950) 1975;115(5):1217-22.
1975: Metcalf D; Moore M A
Growth and responsiveness of human granulocytic leukemic cells in vitro.
Bibliotheca haematologica 1975;(40):235-41.
1974: Moore M A; Spitzer G; Williams N; Metcalf D; Buckley J
Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics.
Blood 1974;44(1):1-18.
1974: Williams N; Moore M A; Shortman K; Condon L; Pike B; Nossal G J
Density separation and characterisation of human blood leucocytes, including T and B lymphocytes.
The Australian journal of experimental biology and medical science 1974;52(Pt 3):491-503.
1974: Metcalf D; Moore M A; Sheridan J W; Spitzer G
Responsiveness of human granulocytic leukemic cells to colony-stimulating factor.
Blood 1974;43(6):847-59.
1974: Moore M A; Spitzer G; Metcalf D; Penington D G
Monocyte production of colony stimulating factor in familial cyclic neutropenia.
British journal of haematology 1974;27(1):47-55.
1974: Ratzan R J; Moore M A; Yunis A A
Effect of chloramphenicol and thiamphenicol on the in vitro colony-forming cell.
Blood 1974;43(3):363-9.
1974: Moore M A; Ekert H; Fitzgerald M G; Carmichael A
Evidence for the clonal origin of chronic myeloid leukemia from a sex chromosome mosaic: clinical, cytogenetic, and marrow culture studies.
Blood 1974;43(1):15-22.
1973: Moore M A; Williams N
Analysis of proliferation and differentiation of foetal granulocyte-macrophage progenitor cells in haemopoietic tissue.
Cell and tissue kinetics 1973;6(5):461-76.
1973: Moore M A; Williams N; Metcalf D
In vitro colony formation by normal and leukemic human hematopoietic cells: characterization of the colony-forming cells.
Journal of the National Cancer Institute 1973;50(3):603-23.
1973: Moore M A; Williams N; Metcalf D
In vitro colony formation by normal and leukemic human hematopoietic cells: interaction between colony-forming and colony-stimulating cells.
Journal of the National Cancer Institute 1973;50(3):591-602.
1973: Moore M A; Metcalf D
Cytogenetic analysis of human acute and chronic myeloid leukemic cells cloned in agar culture.
International journal of cancer. Journal international du cancer 1973;11(1):143-52.
1972: Moore M A; Williams N
Physical separation of colony stimulating cells from in vitro colony forming cells in hemopoietic tissue.
Journal of cellular physiology 1972;80(2):195-206.
1972: Cline M J; Moore M A
Embryonic origin of the mouse macrophage.
Blood 1972;39(6):842-9.
1972: Moore M A; Williams N; Metcalf D
Purification and characterisation of the in vitro colony forming cell in monkey hemopoietic tissue.
Journal of cellular physiology 1972;79(2):283-92.
1971: Janoshwitz H; Moore M A; Metcalf D
Density gradient segregation of bone marrow cells with the capacity to form granulocytic and macrophage colonies in vitro.
Experimental cell research 1971;68(1):220-4.
1971: Warner N L; Moore M A
Defects in hematopoietic differentiation in NZB and NZC mice.
The Journal of experimental medicine 1971;134(2):313-34.
1970: Haskill J S; Moore M A
Two dimensional cell separation: comparison of embryonic and adult haemopoietic stem cells.
Nature 1970;226(5248):853-4.
1970: Metcalf D; Moore M A
Factors modifying stem cell proliferation of myelomonocytic leukemic cells in vitro and in vivo.
Journal of the National Cancer Institute 1970;44(4):801-8.
1970: Moore M A; McNeill T A; Haskill J S
Density distribution analysis of in vivo and in vitro colony forming cells in developing fetal liver.
Journal of cellular physiology 1970;75(2):181-92.
1970: Haskill J S; McNeill T A; Moore M A
Density distribution analysis of in vivo and in vitro colony forming cells in bone marrow.
Journal of cellular physiology 1970;75(2):167-79.
1970: Moore M A; Metcalf D
Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo.
British journal of haematology 1970;18(3):279-96.

Sign-in to see more